<?xml version="1.0" encoding="UTF-8" ?>
<modsCollection xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" xmlns:slims="http://senayan.diknas.go.id" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd">
<mods version="3.3" ID="2348">
<titleInfo>
<title>European Journal of Pharmaceutical Sciences 1 July 2023</title>
</titleInfo>
<typeOfResource manuscript="yes" collection="yes">mixed material</typeOfResource>
<genre authority="marcgt">bibliography</genre>
<originInfo>
<place><placeTerm type="text"></placeTerm></place>
<publisher></publisher>
<dateIssued>2023</dateIssued>
<issuance>monographic</issuance>
<edition>1 July 2023</edition>
</originInfo>
<language>
<languageTerm type="code">id</languageTerm>
<languageTerm type="text">Indonesia</languageTerm>
</language>
<physicalDescription>
<form authority="gmd">Jurnal</form>
<extent></extent>
</physicalDescription>
<note>ABSTRACT
A series of 2-Benzoxyl-Phenylpyridine derivatives were evaluated for their potential antiviral activities against
EV71. The preliminary assays indicated that some of these compounds exhibited excellent antiviral effects on
EV71, they could effectively inhibit virus-induced cytopathic effects (CPEs), reduce progeny viral yields, and

present similar or better antiviral activities compared to the positive control drug ribavirin. Among these de-
rivatives, compounds WY7, WY13 and WY14 showed the most potency against EV71. Investigation of the un-
derlying mechanism of action revealed that these compounds target EV71 replication in cells post infection, they

could profoundly inhibit viral RNA replication and protein synthesis, and inhibit virus-induced cell apoptosis.
Further experiments demonstrated that compound WY7 potently inhibited the activity of the EV71 3C protease
(3Cpro), and to some extent, it affected the activity of 3D polymerase (3Dpol), thus blocking viral replication, but
not the activity of the 2A proteinase (2Apro). Modeling of the molecular binding of the 3Cpro-WY7 complex
revealed that compound WY7 was predicted to insert into the substrate-binding pocket of EV71 3Cpro, blocking
substrate recognition and thereby inhibiting EV71 3Cpro activity. These results indicate that these compounds
might be feasible therapeutic agents against EV71 infection and that these compounds may provide promising
lead scaffolds for the further design and synthesis of potential antiviral agents.</note>
<subject authority=""><topic>3Cpro activity</topic></subject>
<subject authority=""><topic>Antiviral activity</topic></subject>
<subject authority=""><topic>2-benzoxyl-phenylpyridine derivatives</topic></subject>
<classification></classification><identifier type="isbn"></identifier><location>
<physicalLocation>PERPUSTAKAAN SEKOLAH TINGGI ILMU KESEHATAN SAMARINDA REPOSITORY</physicalLocation>
<shelfLocator></shelfLocator>
<holdingSimple>
<copyInformation>
<numerationAndChronology type="1">JIN0131</numerationAndChronology>
<sublocation>Perpus.Akfarsam (Jurnal Farmasi Internasional)</sublocation>
<shelfLocator>615 ASI</shelfLocator>
</copyInformation>
</holdingSimple>
</location>
<slims:digitals>
<slims:digital_item id="2220" url="https://drive.google.com/file/d/1Qsax9oxXdgRoktZnRukGaGg9Bp8IAXKM/view?usp=sharing" path="/https://drive.google.com/file/d/1Qsax9oxXdgRoktZnRukGaGg9Bp8IAXKM/view?usp=sharing" mimetype="text/uri-list">1 July 2023</slims:digital_item>
</slims:digitals><slims:image>1_July_2023.jpeg.jpeg</slims:image>
<recordInfo>
<recordIdentifier>2348</recordIdentifier>
<recordCreationDate encoding="w3cdtf">2026-07-13 07:13:12</recordCreationDate>
<recordChangeDate encoding="w3cdtf">2026-07-13 07:17:59</recordChangeDate>
<recordOrigin>machine generated</recordOrigin>
</recordInfo></mods></modsCollection>